Who We Are
Bioval is a clinical-stage biotech company in the development of solutions for neurodegenerative diseases and it is guided by top-tier medical research faculty.
Our team is composed of neuroscientists, industry leaders with decades of experience across the field and Alzheimer’s therapy developers. Capitalizing on collective learnings in the space, we aim to produce treatments that can substantially impact outcomes—for patients, their families and society.